Log on / register
Feedback | Support | My details
Pathway analysis of kidney cancer using proteomics and metabolic profiling.
Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH
Mol Cancer 2006, 5:64
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma
Arsanious A, Bjarnason GA, Yousef GM
Molecular Cancer 2009, 8:20 (17 March 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Method    
KEGG spider: interpretation of genomics data in the context of the global gene metabolic network
Antonov AV, Dietmann S, Mewes HW
Genome Biology 2008, 9:R179 (18 December 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Review    
Contribution of oncoproteomics to cancer biomarker discovery
Cho WCS
Molecular Cancer 2007, 6:25 (2 April 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.


Research    
Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance
Lin PY, Fosmire SP, Park SH, Park JY, Baksh S, Modiano JF, Weiss RH
Molecular Cancer 2007, 6:16 (14 February 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.